A comprehensive screening and treatment model for reducing disparities in hepatitis B

Area of Science:

• Public Health
• Hepatology
• Health Disparities

Background:

• Chronic hepatitis B disproportionately affects Asian Americans compared to the general US population.
• Limited access to care for immigrant groups stems from knowledge gaps and cultural, linguistic, and financial barriers.
• Hepatitis B infection can lead to significant morbidity and mortality if not appropriately managed.

Purpose of the Study:

• To evaluate the effectiveness of the BfreeNYC pilot program in providing hepatitis B services to underserved minority populations.
• To assess the program's reach, screening, vaccination, and treatment outcomes.
• To determine the program's potential as a model for addressing hepatitis B disparities nationally.

Main Methods:

• The BfreeNYC program offered community education, free screening, vaccinations, and subsidized treatment from 2004 to 2008.
• The pilot targeted immigrants from Asia and other racial/ethnic minority groups in New York City.
• Data collection involved tracking program reach, vaccination rates, and linkage to care for positive cases.

Main Results:

• Nearly 9,000 individuals were reached, with over 2,000 receiving hepatitis B vaccinations.
• 1,162 out of 1,632 individuals who tested positive for hepatitis B received clinical care through the program.
• An increase in reported hepatitis B cases was observed in predominantly Asian neighborhoods during the program's operation.

Conclusions:

• The BfreeNYC program successfully reached its target population and provided essential hepatitis B care, demonstrating effectiveness in addressing health disparities.
• The program's comprehensive approach offers a viable prototype for similar initiatives in other communities nationwide.
• Further research on long-term cost-effectiveness is warranted, but the pilot shows promise for reducing hepatitis B-related health inequities.